The View From The Top: European CEOs Highlight Industry Priorities
Leaders Discuss Concerns And Opportunities For The European Generics And Biosimilars Sector
At a high-profile panel closing out Medicines for Europe’s 30th annual conference in Dublin, six industry leaders set out their views on key topics including pricing, regulation, sustainability, and stakeholder communication.
